Mark Enyedy

Mark Enyedy

DirectoratCharles River Laboratories International· In the 2025 proxy

Mark Enyedy sits on 8 public boards.

Boards1

  • Charles River Laboratories InternationalDirector · 0 yr on the boardIndependentCorporate Governance and Nominating, Strategic Planning and Capital Allocation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Charles River Laboratories InternationalPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  2. Astellas PharmaPublic company
    • Director? – PresentNo stock prices for these years
  3. BioMarinPublic company
    • Director? – PresentNo stock prices for these years
  4. Akebia TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  5. Biotechnology Innovation OrganizationPublic company
    • Director? – PresentNo stock prices for these years
  6. Fate TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  7. Keryx BiopharmaceuticalsPublic company
    • Director? – PresentNo stock prices for these years
  8. LogicBio TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?